Cargando…

Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a

BACKGROUND: Magnetic resonance spectroscopy quantitatively monitors biomarkers of neuron-myelin coupling (N-acetylaspartate (NAA)), and inflammation (total creatine (tCr), total choline (tCho), myo-inositol (mI)) in the brain. OBJECTIVE: This study aims to investigate how ocrelizumab and interferon...

Descripción completa

Detalles Bibliográficos
Autores principales:	MacMillan, Erin L, Schubert, Julia J, Vavasour, Irene M, Tam, Roger, Rauscher, Alexander, Taylor, Carolyn, White, Rick, Garren, Hideki, Clayton, David, Levesque, Victoria, Li, David KB, Kolind, Shannon H, Traboulsee, Anthony L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796216/ https://www.ncbi.nlm.nih.gov/pubmed/31662881 http://dx.doi.org/10.1177/2055217319879952

Ejemplares similares

Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a
por: Kolind, Shannon, et al.
Publicado: (2022)

Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosis
por: O'Muircheartaigh, Jonathan, et al.
Publicado: (2019)

Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?
por: Lee, Lisa Eunyoung, et al.
Publicado: (2019)

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
por: Ackermans, Nathalie, et al.
Publicado: (2019)

Deep learning of joint myelin and T1w MRI features in normal-appearing brain tissue to distinguish between multiple sclerosis patients and healthy controls
por: Yoo, Youngjin, et al.
Publicado: (2017)

Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS
por: Arnold, Douglas L, et al.
Publicado: (2022)

Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica
por: Manogaran, Praveena, et al.
Publicado: (2016)

Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging
por: Kolind, Shannon, et al.
Publicado: (2023)

Longitudinal advanced MRI case report of white matter radiation necrosis
por: Wiggermann, Vanessa, et al.
Publicado: (2018)

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a
por: Havrdová, Eva, et al.
Publicado: (2018)

Data fusion detects consistent relations between non-lesional white matter myelin, executive function, and clinical characteristics in multiple sclerosis
por: Baumeister, Tobias R., et al.
Publicado: (2019)

Endocarditis following ocrelizumab in relapsing-remitting MS
por: Faissner, Simon, et al.
Publicado: (2020)

Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab
por: Moreira Ferreira, Vanessa F., et al.
Publicado: (2019)

Accounting for uncertainty in training data to improve machine learning performance in predicting new disease activity in early multiple sclerosis
por: Tayyab, Maryam, et al.
Publicado: (2023)

Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progression
por: Law, Marco TK, et al.
Publicado: (2019)

Rapid myelin water imaging for the assessment of cervical spinal cord myelin damage
por: Dvorak, Adam V., et al.
Publicado: (2019)

Quantitative MRI findings indicate diffuse white matter damage in Susac Syndrome
por: Johnson, P, et al.
Publicado: (2022)

Ocrelizumab initiation in patients with MS: A multicenter observational study
por: Ellwardt, Erik, et al.
Publicado: (2020)

Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
por: Fernández-Velasco, José I., et al.
Publicado: (2021)

Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension
por: Hauser, Stephen L., et al.
Publicado: (2020)

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
por: Turner, Benjamin, et al.
Publicado: (2019)

Both Stationary and Dynamic Functional Interhemispheric Connectivity Are Strongly Associated With Performance on Cognitive Tests in Multiple Sclerosis
por: Lin, Sue-Jin, et al.
Publicado: (2020)

Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis
por: Barkhof, Frederik, et al.
Publicado: (2019)

Ventriculomegaly associated with ependymal gliosis and declines in barrier integrity in the aging human and mouse brain
por: Shook, Brett A, et al.
Publicado: (2014)

Inter-Vendor Reproducibility of Myelin Water Imaging Using a 3D Gradient and Spin Echo Sequence
por: Lee, Lisa Eunyoung, et al.
Publicado: (2018)

Comparison of multi echo T(2) relaxation and steady state approaches for myelin imaging in the central nervous system
por: Dvorak, Adam V., et al.
Publicado: (2021)

Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MS
por: Hartung, Hans-Peter
Publicado: (2020)

Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
por: Emery, Paul, et al.
Publicado: (2014)

Myelin Water Fraction Is Transiently Reduced after a Single Mild Traumatic Brain Injury – A Prospective Cohort Study in Collegiate Hockey Players
por: Wright, Alexander D., et al.
Publicado: (2016)

Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis
por: Lee, Lisa Eunyoung, et al.
Publicado: (2021)

Activated gliosis, accumulation of amyloid β, and hyperphosphorylation of tau in aging canines with and without cognitive decline
por: Hines, Amelia D., et al.
Publicado: (2023)

Deformation-based morphometry identifies deep brain structures protected by ocrelizumab
por: Song, Zhuang, et al.
Publicado: (2022)

Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS
por: Novi, Giovanni, et al.
Publicado: (2020)

Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2023)

Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis()
por: Tam, Roger C., et al.
Publicado: (2012)

Immature Teratoma With Metastatic Gliosis
por: Ahoussougbemey Mele, Ange, et al.
Publicado: (2022)

Ocrelizumab-Induced Severe Colitis
por: Lee, Hsing Hwa, et al.
Publicado: (2020)

4395 alpha-Synuclein Induced Reactive Gliosis
por: Carey, Sean David, et al.
Publicado: (2020)

Cervical Spinal Cord Atrophy can be Accurately Quantified Using Head Images
por: Taheri, Kamyar, et al.
Publicado: (2022)

COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
por: Novi, Giovanni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_753qgrebtqhcarono1n5196u00